基础医学与临床 ›› 2010, Vol. 30 ›› Issue (9): 907-911.

• 研究论文 • 上一篇    下一篇

肺鳞癌细胞单克隆抗体的建立及鉴定

唐睿珠 李继梅 边莉 马丽菊 郝萍 王秦秦   

  1. 昆明医学院第一附属医院临床医学实验研究中心
  • 收稿日期:2009-12-07 修回日期:2010-03-23 出版日期:2010-09-05 发布日期:2010-09-05

Preparation and identification of monoclonal antibodies to YTMLC-90 cells

Rui-zhu TANG, Ji-mei LI, Li BIAN, Li-ju MA, Ping HAO, Qin-qin WANG   

  1. The Clinical Medicine Research Center, The First Affiliated Hospital,Kunming Medical College
  • Received:2009-12-07 Revised:2010-03-23 Online:2010-09-05 Published:2010-09-05

摘要: 目的 制备出高效价的抗人肺鳞癌单克隆抗体。方法 以云南个旧肺鳞癌细胞YTMLC -90免疫的Balb/C小鼠脾细胞和小鼠骨髓瘤NS-1、SP2/0细胞为亲代细胞,应用鼠-鼠杂交瘤技术建立杂交瘤细胞系。ELISA法筛选,有限稀释法克隆化培养,ELISA法测定抗体效价,双抗体夹心法鉴定Ig亚类,制备染色体,Giemsa染色计数染色体数目,ABC免疫组化法行不同组织细胞的交叉检测。结果 获得三株稳定分泌抗YTMLC-90细胞抗体的杂交瘤细胞株S2D1、N2D1及N3C5。培养上清效价分别为1∶512、1∶284及1∶1024,腹水效价分别为1∶105、1∶104及1∶104;Ig亚类分别为IgG1、IgG2a及IgG3;染色体众数在90~110之间;三株抗人肺鳞癌单克隆抗体与其它组织细胞无交叉反应性。杂交瘤细胞体外传代培养6个月仍保持抗体稳定分泌。结论 成功制备高效且特异的抗人肺癌单克隆抗体。

Abstract: Objective To obtain hybridoma cell lines which can secrete high-titer monoclonal antibodies against human lung squamous cell carcinoma YTMLC-90 cell line. Methods Balb/c mice were immunized by a human lung squamous cell carcinoma YTMLC-90 cell line. And the immunized splenocytes were fused separately with two murine myeloma cell lines SP2/0 and NS-1 using hybridoma technique. And then, positive hybridomas were selected to cloned culture and subcloned by limited dilution. The titers of McAbs from cell culture supernatant and ascites were assayed by ELISA. The isotype of the McAbs were also identified by ELISA and the average number of chromosome of the hybridoma cell lines were counted by a general method after stained with Gimesa. McAb's cross-reaction with different cells and tissues were detected by ABC immunohistochemistry technique. Results Stable hybridomas S2D1, N2D1, N3C5 were constructed. The titers of these 3 McAbs from cell culture supernatant and ascites were 1:512,1:284,1:1024 and 1:105,1:104,1:104 respectively. The isotypes were IgG1, IgG2a and IgG3. The numbers of chromosome were 90~110. No cross-reaction with other cell lines and tissues. Conclusion Specific and high titer antibodies against human lung cancer were successfully prepared.